Rigel Pharma (RIGL.US) Stock Community - Hot Topic Discussions

Event Tracking

Nov5

Rigel Pharma released FY2025 Q3 earnings on November 4 After-Market EST, actual revenue USD 69.46 M (forecast USD 61.88 M), actual EPS USD 1.46 (forecast USD 0.9025)

00:00

Rigel Pharma released FY2025 9 Months earnings on November 4, 2025, After-Market EST, with actual revenue of USD 224.48 M and actual EPS of USD 5.37

00:00

Nov4

Rigel Pharmaceuticals Exceeds Q3 Revenue Expectations and Raises Full-Year Guidance

21:16

Oct28

Rigel Pharma to Release FY2025 Q3 Earnings on November 4 After-Market EST, Forecast Revenue USD 61.88 M, EPS USD 0.738

00:05

Oct8

Rigel Begins Dose Expansion Phase of R289 for Low-Risk MDS 1b Study

12:06

Aug5

Rigel Pharma released FY2025 Semi-Annual earnings on August 5 After-Market EST, actual revenue USD 155.02 M (forecast USD 142.04 M), actual EPS USD 3.91 (forecast USD 3.16)

23:00